The prognostic significance of nonsentinel lymph node metastasis in melanoma

Annals of Surgical Oncology

Volumn 17, Issue 12, 2010, Pages 3330-3335

  Brown, Russell E ^a   Ross, Merrick I ^b   Edwards, Michael J ^c   Noyes, R Dirk ^d   Reintgen, Douglas S ^e   Hagendoorn, Lee J ^f   Stromberg, Arnold J ^g   Martin, Robert C G ^a   McMasters, Kelly M ^a   Scoggins, Charles R ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d LDS HOSPITAL   (United States)

^e Lakeland Regional Cancer Center   (United States)

^f Advertek Inc   (United States)

^g UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBINTERFERON ALPHA2B;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; NONSENTINEL LYMPH NODE METASTASIS; OVERALL SURVIVAL; PROGNOSIS;

ADOLESCENT; ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL RATE; YOUNG ADULT;

EID: 78650979812     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1208-8     Document Type: Article

References (20)

1. DL Morton DR Wen JH Wong JS Economou LA Cagle FK Storm, et al. 1992 Technical details of intraoperative lymphatic mapping for early stage melanoma Arch Surg. 127 392 399 1:STN:280:DyaK383hsFWjsw%3D%3D 1558490
2. JE Gershenwald W Thompson PF Mansfield JE Lee MI Colome CH Tseng, et al. 1999 Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients J Clin Oncol. 17 976 983 1:STN:280:DyaK1M7mvVymsg%3D%3D 10071292
3. CM Balch JE Gershenwald SJ Soong JF Thompson MB Atkins DR Byrd, et al. 2009 Final version of 2009 AJCC melanoma staging and classification J Clin Oncol. 27 6199 6206 10.1200/JCO.2009.23.4799 19917835
4. CM Balch DL Morton JE Gershenwald KM McMasters OE Nieweg B Powell, et al. 2009 Sentinel node biopsy and standard of care for melanoma J Am Acad Dermatol. 60 872 875 10.1016/j.jaad.2008.09.067 19389531
5. Practice Guidelines in Oncology. Vol. 1. 2010: National Comprehensive Cancer Networks; 2009:ME-3.
6. DL Morton JF Thompson AJ Cochran N Mozzillo R Elashoff R Essner, et al. 2006 Sentinel-node biopsy or nodal observation in melanoma N Engl J Med. 355 1307 1317 1:CAS:528:DC%2BD2sXisVaqtr4%3D 10.1056/NEJMoa060992 17005948 (Pubitemid 44465459)
7. JE Gershenwald RH Andtbacka VG Prieto MM Johnson AH Diwan JE Lee, et al. 2008 Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma J Clin Oncol. 26 4296 4303 10.1200/JCO.2007.15.4179 18606982
8. KM McMasters SL Wong MJ Edwards C Chao MI Ross RD Noyes, et al. 2002 Frequency of nonsentinel lymph node metastasis in melanoma Ann Surg Oncol. 9 137 141 10.1007/BF02557364 11888869 (Pubitemid 34259698)
9. ME Reeves R Delgado KJ Busam MS Brady DG Coit 2003 Prediction of nonsentinel lymph node status in melanoma Ann Surg Oncol. 10 27 31 10.1245/ASO.2003.03.020 12513956
10. MS Sabel K Griffith VK Sondak L Lowe JL Schwartz VM Cimmino, et al. 2005 Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma J Am Coll Surg. 201 37 47 10.1016/j.jamcollsurg.2005. 03.029 15978442 (Pubitemid 40840562)
11. I Satzger B Volker A Meier A Kapp R Gutzmer 2008 Criteria in sentinel lymph nodes of melanoma patients that predict involvement of nonsentinel lymph nodes Ann Surg Oncol. 15 1723 1732 10.1245/s10434-008-9888-z 18389323
12. A Cadili M Smylie J Danyluk K Dabbs 2009 Prediction of nonsentinel lymph node metastasis in malignant melanoma J Surg Res. 154 324 329 10.1016/j.jss.2008.06.012 19101696
13. N Cascinelli E Bombardieri R Bufalino T Camerini A Carbone C Clemente, et al. 2006 Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival J Clin Oncol. 24 4464 4471 10.1200/JCO.2006.06.3198 16983115 (Pubitemid 46630985)
14. F Roka P Mastan M Binder I Okamoto M Mittlboeck R Horvat, et al. 2008 Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients Eur J Surg Oncol. 34 82 88 1:STN:280:DC%2BD2sjlvFGksQ%3D%3D 17360144
15. C Ariyan MS Brady M Gonen K Busam D Coit 2009 Positive nonsentinel node status predicts mortality in patients with cutaneous melanoma Ann Surg Oncol. 16 186 190 10.1245/s10434-008-0187-5 18979135
16. AA Ghaferi SL Wong TM Johnson L Lowe AE Chang VM Cimmino, et al. 2009 Prognostic significance of a positive nonsentinel lymph node in cutaneous melanoma Ann Surg Oncol. 16 2978 2984 10.1245/s10434-009-0665-4 19711133
17. KM McMasters DS Reintgen MI Ross SL Wong JE Gershenwald DN Krag, et al. 2001 Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed? Ann Surg Oncol. 8 192 197 1:STN:280:DC%2BD3M3itVGquw%3D%3D 10.1007/s10434-001-0192-4 11314933
18. CR Scoggins RC Martin MI Ross MJ Edwards DS Reintgen MM Urist, et al. 2010 Factors associated with false-negative sentinel lymph node biopsy in melanoma patients Ann Surg Oncol. 17 709 717 10.1245/s10434-009-0858-x 19967459
19. CR Scoggins MI Ross DS Reintgen RD Noyes JS Goydos PD Beitsch, et al. 2006 Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma J Clin Oncol. 24 2849 2857 1:CAS:528:DC%2BD28XntV2gsrs%3D 10.1200/JCO.2005.03.2342 16782924 (Pubitemid 46630585)
20. DL Morton 2004 Sentinel node mapping and an International Sentinel Node Society: current issues and future directions Ann Surg Oncol. 11 137S 143S 15023740